Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2002
06/18/2002CA2356812A1 Tnf-alpha production inhibitor comprising kavalactone as an active ingredient
06/18/2002CA2191850C Cancerous metastasis inhibitor
06/13/2002WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha
06/13/2002WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer
06/13/2002WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders
06/13/2002WO2002046459A2 Method for the determination of at least one functional polymorphism in the nucleotide sequence of a preselected candidate gene and its applications
06/13/2002WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
06/13/2002WO2002046423A2 Protein derived from the melanin-concentrating hormone (mch), corresponding nucleic acids and their use for preparing medicines
06/13/2002WO2002046418A2 Lipid-associated molecules
06/13/2002WO2002046412A2 Regulation of angiogenesis with zinc finger proteins
06/13/2002WO2002046411A2 Intestinal proteins
06/13/2002WO2002046409A2 Proteins and nucleic acids encoding same
06/13/2002WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
06/13/2002WO2002046385A2 Enzymes
06/13/2002WO2002046384A2 Kinases and phosphatases sequences, and use thereof
06/13/2002WO2002046383A2 Protein modification and maintenance molecules
06/13/2002WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/13/2002WO2002046232A2 Multimeric single-chain antibody with multiple antigen binding
06/13/2002WO2002046230A2 G-protein coupled receptors
06/13/2002WO2002046226A2 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
06/13/2002WO2002046224A2 Compositions and methods relating to lung specific genes and proteins
06/13/2002WO2002046216A2 Human sprouty-4 polypeptide
06/13/2002WO2002046210A1 Method for preparing tryptophan rich peptides
06/13/2002WO2002046203A1 A substance or composition for the treatment of cancer
06/13/2002WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors
06/13/2002WO2002046196A1 Process for the isolation and purification of epothilones
06/13/2002WO2002046194A2 Substituted imidazopyridines
06/13/2002WO2002046193A2 Heterocyclic ether substituted imidazoquinolines
06/13/2002WO2002046192A2 Thioether substituted imidazoquinolines
06/13/2002WO2002046191A2 Urea substituted imidazoquinoline ethers
06/13/2002WO2002046190A2 Sulfonamido ether substituted imidazoquinolines
06/13/2002WO2002046189A2 Aryl ether substituted imidazoquinolines
06/13/2002WO2002046188A2 Amido ether substituted imidazoquinolines
06/13/2002WO2002046186A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
06/13/2002WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
06/13/2002WO2002046183A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
06/13/2002WO2002046182A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
06/13/2002WO2002046180A1 Klainetin and derivatives thereof, method for their production and the use of the same
06/13/2002WO2002046177A1 A process for the preparation of paclitaxel
06/13/2002WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
06/13/2002WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002WO2002046169A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
06/13/2002WO2002046168A1 Therapeutic benzimidazole compounds
06/13/2002WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002WO2002046164A1 Therapeutic compounds
06/13/2002WO2002046154A1 Peroxisome proliferator activated receptor d activators
06/13/2002WO2002046148A1 Substituted anthranilic acids
06/13/2002WO2002046147A2 Perturbed membrane-binding compounds
06/13/2002WO2002046144A1 Tetralone derivatives as antitumor agents
06/13/2002WO2002046134A1 Novel estrogen receptor ligands and methods iii
06/13/2002WO2002045755A2 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
06/13/2002WO2002045747A1 Immunotherapeutic combinations for the treatment of tumors
06/13/2002WO2002045746A2 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
06/13/2002WO2002045740A1 Compositions containing gangliosides for use in the treatment of skin disorders
06/13/2002WO2002045739A1 Immunomodulatory constructs and their uses
06/13/2002WO2002045738A2 Vaccine composition containing transforming growth factor alpha
06/13/2002WO2002045737A2 Methods of treatment involving human mda-7
06/13/2002WO2002045730A1 Antimonocytic activity of extracts of piper betel leaves
06/13/2002WO2002045716A1 Use of pyrazolo[4,3-d]pyrimidines
06/13/2002WO2002045711A1 Use of anti-muscarinic agents and calcium channel blockers in combination
06/13/2002WO2002045708A2 Use of zwitterionic polysaccharides for the specific modulation of immune processes
06/13/2002WO2002045707A2 Polynucleotide intercalator interceptors and inhibitors
06/13/2002WO2002045696A1 Drug delivery system
06/13/2002WO2002045654A2 Cancer preventative effect of morinda citrifolia
06/13/2002WO2002045652A2 Tyrosine kinase inhibitors
06/13/2002WO2002045590A1 Method for regional administeration of preparations for curing liver tumors
06/13/2002WO2002030906B1 Anti-tumour compounds
06/13/2002WO2002026929A3 Kini-3 motor protein and methods for its use
06/13/2002WO2002026706A3 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
06/13/2002WO2002024686A3 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
06/13/2002WO2002024224A3 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
06/13/2002WO2002022848A3 Compositions comprising mixtures of human cytokines and methods of producing the same
06/13/2002WO2002022130A3 Means for regulating immune defences
06/13/2002WO2002017857A3 Methods and compositions for inhibiting angiogenesis
06/13/2002WO2002016362A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002016361A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002016360A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002015891A3 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
06/13/2002WO2002012339A3 Sequences for integrin alpha-8
06/13/2002WO2002012245A3 Azabicyclic derivatives and their therapeutic use
06/13/2002WO2002008263A3 Modified virus having an altered tropism
06/13/2002WO2002008219A3 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
06/13/2002WO2002007712A3 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
06/13/2002WO2002004404A3 7,8 and 9-substituted tetracycline compounds
06/13/2002WO2001098350A3 Compositions comprising net-4 modulations and their use for treating neoplastic disease
06/13/2002WO2001098277A3 Substituted bicyclic derivatives for the treatment of abnormal cell growth
06/13/2002WO2001097618A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
06/13/2002WO2001096330A3 Thrombin receptor antagonists
06/13/2002WO2001095884A3 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
06/13/2002WO2001094415A3 Nuclear hormone receptor
06/13/2002WO2001092294A3 Therapeutic anti-melanoma compounds
06/13/2002WO2001091781A3 Thrombospondin type 1 repeat polypeptides
06/13/2002WO2001090159A3 Compositions and methods for delivery of a molecule into a cell
06/13/2002WO2001090104A3 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
06/13/2002WO2001083687A3 A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide
06/13/2002WO2001083438A3 New gamma selective retinoids
06/13/2002WO2001082899A3 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
06/13/2002WO2001079425A3 A novel polypeptide - human chloride channel protein 10 and the polynucleotide encoding said polypeptide
06/13/2002WO2001079198B1 Pyrazoles for inhibiting protein kinase
06/13/2002WO2001077057A3 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
1 ... 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 ... 2211